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ABSTRACT 
 
Non-toxic biosensors are encountering an increase in attention for use in 
understanding the fate of cells and as a diagnostic tool. Development and 
incorporation of suitable fluorophores into biological molecules is the key for 
monitoring proteins in vivo research. This study investigated the enhanced 
emission of Eu (III) and Tb (III) upon binding to the four DNA bases and their 
respective nucleotides, found the best ratio for effective energy transfer, and 
developing nanoparticles to deliver the biosensor into the cells. 
 
It is well known that Eu (III) and Tb (III) exhibit very distinctive photo-
characteristics.  The luminescence of these two lanthanides is weak due to low 
absorption cross sections.  Conversely, the emission of both trivalent ions, upon 
irradiation, in aqueous solution, is strong when bound to complex ligand systems.  
The luminescent enhancement is the result of energy transfer (EnT) and the 
binding with single-stranded DNA, making these ions perfect candidates for 
luminescent probes (1).  The emission lanthanides theory by G.A. Crosby 
establishes that the intramolecular energy transfer in a lanthanide complex is 
when the lowest triplet state energy level of the complex equals or lies above the 
resonance level of the lanthanide (2)   
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To overcome the inherently low absorption of lanthanide ions, researchers have 
developed sensitizing fluorophores that upon excitation, transfer energy to the  
lanthanide (3) (4).  One problem with luminescence in an aqueous solution is that 
another pathway is available for deactivation of the excited state of the lanthanide, 
in the form of vibrational energy transfer to water molecules (1). Early research 
shows that quenching of luminescence is minimized by using ligands which 
tended to encapsulate the lanthanide ion (1).  Longer emission lifetimes and greater 
quantum yield intensities can be accomplished by either chelation by ligands (5) or 
encapsulation of the lanthanides.  We ascertained the maximum enhancement for 
the lanthanide ions occurred through the interaction with the base guanine or its 
nucleotide guanosine 5’-monophosphate disodium salt.   
 
The research initially pursued the encapsulation of the lanthanide ions by single-
strand oligonucleotides as a biosensor. However, an alternative delivery method 
based on inverse micelles and liposomes was developed and it proved to be 
economical and simple to encapsulate and deliver the biosensor into the cells.  
The creation of a double emulsion, or water-oil-water system, and the 
encapsulation (using palmitic acid as surfactant) of the water soluble biosensors 
were successful.  This thesis determined the particle size achieved of 75nm, for 
both lanthanides had fallen into the nanoemulsions range.  Their small size 
permits the nanoparticles to be injected intravenously (6).   
 
xiii 
 
The in vitro toxicity of the nanoparticles, with both luminescence biosensors, was 
assessed by BCA assay.  Results supported both luminescence nanoparticles 
biosensors were non toxic to human cells.  Therefore, these NP’s have a potential 
to provide a unique detection signature as a contrast agent suitable for medical 
applications (7). 
 
It has been published that nanoparticles (NPs) can rapidly be transported to the 
liver (about 90%), then kidneys and other organs (8).  After a period of time, the 
NPs are expelled from the human body through feces and urine, unless the size of 
the NPs is larger than 200 nm, in which case the NPs are retained / trapped by the 
liver. The particle size obtained in this research, 75nm, is a good indication that 
the biosensor will have a safe disposal from the body.   
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1. INTRODUCTION 
Non-toxic biosensors are experiencing an increase interest due to the need to 
understand the fate of cells and as a diagnostic tool. Development and 
incorporation of appropriate fluorophores into biological molecules is the key for 
proteins in vivo research. It is well known that Eu (III) and Tb (III) exhibit very 
unique photo-characteristics upon irradiation.  
 
It has been shown that the emissive lanthanide properties of Eu (III) and Tb (III), 
including their luminescence enhancement through energy transfer, and their 
ability to bind single-stranded regions of DNA make these ions the perfect 
candidates for life-cell imaging system. Additionally, single-stranded 
oligonucleotides are known to enhance the emission of Eu (III) and Tb (III) ions 
in solution (1).  Previous studies have confirmed that lanthanide ions also bind 
oligonucleotides (9) (10) , and the resulting bioconjugates provide in the monitoring 
of hybridization reactions and phosphodiesterase activity by FRET, Föster 
resonant energy transfer, technology (11) (12). 
. 
As stated earlier, it is well known that Eu (III) and Tb (III) exhibit very unique 
photo-characteristics upon irradiation. To overcome the inherently low absorption 
of lanthanide ions, researchers have developed sensitizing fluorophores that upon 
excitation, transfer energy to the lanthanide (13) (4).  There is a major problem with 
luminescence in an aqueous solution that another pathway is available for 
deactivation of the excited state of the lanthanide, in the form of vibrational 
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energy transfer to water molecules in particular.  This quenching of luminescence 
can be minimized by using ligands which tend to encapsulate the lanthanide ion 
(1).  To overcome the weak luminescence in aqueous solution of Eu (III) and Tb 
(III), addition of chelating agents or encapsulation of the lanthanides leads to 
longer emission lifetimes and quantum yields. 
 
Our research pursues the encapsulation of the lanthanides. Encapsulation is to 
protect the enclosed lanthanides from substances or processes in the vicinity of 
these capsules. The unique optical property of Eu(III) and Tb(III) 
Nanoparticles(NP) will provide us a new live-cell imaging system which is safe, 
photostable, and photosensitive. The stability both in the excited state and in 
oxidation state makes these lanthanides good imaging molecules to monitor 
cellular activities such as enzymatic reactivity, DNA hybridization, drug binding, 
electron transfer, and nucleic acid solvation environment. 
 
The ultimate goal of this thesis study is to develop a delivery mechanism that 
packages theses two lanthanides into a biosensor, insert the biosensor into the 
bloodstream and release it at the specific point of interest (14).  
 
We discovered that the maximum enhancement for the lanthanide ions occurred 
through the interaction with the base guanine (G) and the phosphate groups of its 
nucleotide guanosine 5’-monophosphate disodium salt (GMP), (Figure 1 and 2).  
It was found that guanine enhances both of the trivalent ions emission with Eu 
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(III) being more emissive.  In accordance with literature research, energy transfer 
from intrinsic fluorophores, such as nucleic acids, generally gave rise to enhanced 
Eu (III) and Tb (III) emission (15).  However, the results which are to be discussed 
later, shows Eu (III) opposed this statement. 
 
Although previous studies reported energy transfer from the bases (C and G) and 
nucleotide 5’-deoxymonophosphate (dGMP), unexpected behavior of the 2’ 
deoxyguanosine 5’-triphosphate disodium salt (dGTP) nucleotide was found. 
Actually, none of the triphosphate nucleotides enhanced the fluorescence of the 
trivalent ions.  Phosphate interference was determined as the main cause for 
unsuccessful energy transfer.  Research has shown that in the cases of G and 
dGMP, the phosphate group appears to aid in the biding of the donor and 
acceptor.  A comparison of the enhanced luminescence among GMP with its 
triphosphate and diphosphate analogues, GTP and GDP, respectively, has shown 
that GMP is a better energy transfer donor in the order GMP> GDP > GTP (16) (17).  
The results indicated that the lanthanide bounded to the monophosphate group 
(GMP) was closer for effective energy transfer than the triphosphate groups 
(dGTP). The degree of enhancement of GMP bound to Tb (III) was greater than 
for Eu (III), respectively. The enhancement of the trivalent ions by GMP was 
much greater than the base G. 
 
Toxicity studies through BCA assay, (bicinchoninic acid), determined that our 
nanosensors were non-cytotoxic.  The w/o/w double emulsion technique 
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successfully created nanoparticles which encapsulate the water soluble biosensor. 
A TEM image showed that the size of the particle was 75 nm, which fell into the 
nanoemulsions range (Figure 29).   
 
The choice of the rare earths or lanthanides was not arbitrarily chosen. The rare 
earths (RE) form a group of chemically similar elements which have in common 
an open 4f shell.  They are chiefly trivalent and it is principally the properties of 
the trivalent ions which are important rather than those of the neutral atoms. They 
are strongly paramagnetic, in some cases ferromagnetic or anti-ferromagnetic at 
low temperatures. Their trivalent salts have absorption spectra and in some cases 
fluorescence spectra with sharp lines in the visible or neighboring spectral regions 
(27).  Some trivalent lanthanide ions exhibit excellent luminescence characteristics 
when the native luminescence is enhanced by coordination with suitable organic 
ligands.   
 
Having chosen the lanthanides Eu (III) and Tb (III), the design of the biosensor 
was the next crucial step and was based on chemical, photo-physical and 
biochemical guidelines published from literature research. For in vivo 
experiments, the matter of toxicity is highly critical, as well as the ability of the 
probe to be excreted in a reasonable span of time (typically 12-48 h).  Lanthanides 
are relatively innocuous due to poor absorption in the gastrointestinal track and, 
even when injected, normally cannot penetrate living cells (19; 20).  According to 
the systematic studies published to date, extraordinary rules have been established 
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based on a simplistic model which the main energy transfer path implies the 
ligand triplet state and that the only parameter of importance is the energy gap 
between this state and the emitting Ln(III) level (21) (22) (23). 
 
Figure 1.  Structure of the four DNA bases  
 
 
Figure 2.  Structure of dGTP & GMP Nucleotides 
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1.a.  Spectroscopic characteristics of Europium and Terbium 
 
The trivalent ions of Eu (III) and Tb (III) show excellent luminescence 
characteristics when enhanced by coordination with suitable ligands. The 
enhancement of luminescence intensity by complexation of the tri-positive 
luminescent lanthanide, Ln (III) ions, has been explained on the basis of a ligand-
to-metal energy transfer mechanism (24).  The mechanism for energy transfer was 
derived from research by Kasha, Crosby, and their co-workers (30) . (See Figure 3.)  
When an excited triplet state of the coordinating ligand overlaps a lanthanide 
excited electronic level, the lanthanide luminescence is pumped by a large cross 
section molecular absorbance, rather than by its own weak absorbance. To 
understand the photo-physics and photochemistry of the lanthanides see energy 
level diagram, Figure 4. (3)  This diagram illustrates the largest gaps in energy 
level bands for Eu (III) and Tb (III). Eu (III) has a regular 7F multiplet as ground 
multiplet followed by a 5D multiplet.  At low temperatures, the absorption 
spectrum in the visible is due to the transitions from the ground state 7F0 to 5D0, 
5D1, 5D2, 5D3.  Shortly above the level 5D3, a whole series of levels is found and 
the situation is that the expected levels are so crowded that a detailed analysis is 
difficult (27).   
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Figure 3.  Schematic diagram of the ligand-to-lanthanide energy transfer (28). 
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Figure 4.  Energy Level Diagram 
 
 
 
1.b.  Nanoparticles Design for biosensor delivery 
 
Nanoparticles were designed by utilizing the characteristic behavior of dual 
structure, hydrophilic and hydrophobic region in a single molecule. The delivery 
system must have the property of solubilizing the aqueous biosensor in a 
hydrophilic (polar) micelle core. Using amphipathic molecules which are 
everywhere in biological systems.  The nanoparticles were designed by using 
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inverse micelles and double emulsions (Figures 5, 6 and 7).  Two particular 
amphiphilic molecules were chosen. One was a synthetic surfactant: palmitic acid 
which is anionic, has low toxicity and forms charged micelles that can bind to 
oppositely charged particles.  Second one was a membrane lipid: phospholipids, 
particularly phosphatidylcholine, which is used for preparation of vesicle 
suspensions commonly called liposomes or as monolayers (34) (Figure 5).  
Effective delivery and release of the biosensor were the main purpose of the 
nanoparticles design. 
 
Palmitic acid or hexadecanoic acid was selected because it is one of the most 
common saturated fatty acids found in animals and plants.   Phospholipid micelles 
were chosen due to the fact they are an ideal drug and biosensor carrier.  
 
Figure 5.  Liposome (35) 
 
 
10 
 
 
Phospholipid micelles are ideal drug carrier systems for multiple reasons.  First, 
the phospholipid nanoparticles are biocompatible and biodegradable.  Second, 
preparation is simple and reproducible (33).  Finally, phospholipids improved in 
vitro and in vivo stability, bioactivity, targetability and reduced toxicity (33).    
 
Disadvantages are the body can identify the liposomes as foreign intruders and 
destroy the delivery vehicle. Also, liposomes are very sensitive to temperature, 
surfactant concentration, and moisture 
 
The nanoparticles were formed by creating inverse micelles and then invert the 
emulsion.  The supramolecular living aggregates can be formed by dissolving 
surfactants in strongly polar or totally apolar solvents (oils).  A schematic 
representation of reversed micelle is shown in Figure 6.   
 
As stated before the building blocks to our delivery mechanism are molecules 
called amphiphiles.  The strategy devised the use of amphiphiles introduced into 
an oily liquid (forming reverse micelles) and then obtained a double emulsion.   
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Figure 6.  Schematic Representation of a Reverse Micelle (35).  
 
 
Figure 7.  Schematic Representation of Water in Oil emulsion (39).  
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The difference between reverse micelles and w/o microemulsions is that in the 
micelles the emphasis is on the surfactant forming the aggregate, while in 
microemulsions the amount of solubilizate compartmentalize in the micellar core 
constitutes a relevant part of the entire aggregate.  
 
It is one thing to produce nanoemulsions, it is another thing to determine if they 
were formed. Different methods such as NMR self-diffusion, transmission 
electron microscopy (TEM) and scattering techniques (small angle X-ray 
scattering (SAXS)) and small angle neutron scattering (SANS) provide 
information of the structure and dynamics of microemulsions and nanoemulsions.  
 
Size and shape of a droplet microemulsions and nanoemulsions can be 
investigated using a combination of different scattering techniques.  Small angle 
neutron scattering (SANS) is an excellent tool to study the shape, size and 
polydispersity of the microemulsion droplets.  The translational diffusion of the 
droplets can be studied using dynamic light scattering (DLS).  Finally, neutron 
spin-echo spectroscopy (NSE) gives direct access to the shape fluctuations of the 
droplets (40). 
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2. MATERIALS  AND METHODS 
 
2. a. Materials 
Materials were obtained from commercial suppliers and used without further 
purification.  Analytical reagent grade chemicals were used along with de-ionized 
water to prepare solutions.  Lanthanides chlorides were obtained in purities of 
99%.  Stock solutions of different concentrations of the lanthanides were prepared 
by dissolving a known amount of trivalent ions in PBS or water (refers to table 1 
and table 2).  A series of serial dilutions were made with PBS at first for the 
triphosphate nucleotides and later with de-ionized water, for both the triphosphate 
and monophosphate nucleotides.  
 
Lanthanides 
• Europium(III) chloride powder, EuCl3,  
Purity: 99.9%; was obtained from Aldrich. 
F.W=258.3, Lot number: 05585JJ,  
Appearance: pale yellow powder. CAS 10025-76-0, mp 850 OC 
• Terbium(III) chloride anhydrous powder, TbCl3, 
 Purity:  99.9% was obtained from Aldrich.  
F.W=265.28, Lot number: MKAA3919, 
Appearance: white powder. CAS 10042-88-3 mp 588 OC. 
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Nucleotides: 
• 2’ Deoxyadenosine 5’-triphosphate disodium salt (dATP), 97%, F.W= 
535.15 Sigma Aldrich D6500-10MG 
• 2’ Deoxycytidine  5’-triphosphate disodium salt (dCTP), 95%, F.W= 
511.1 Sigma Aldrich D4635-10MG 98% Purity (HPLC); 4 % Solvent;  
• 2’ Deoxyguanosine 5’-triphosphate sodium salt (dGTP), 96%, 
F.W=507.18 Sigma Aldrich D4010-10MG 
• 2’ Deoxythymidine  5’-triphosphate sodium salt (dTTP), 96%, F.W=482.2 
Sigma Aldrich T0251-10MG 
• Adenosine 5’-monophosphate disodium salt (AMP), 99%, F.W=391.18, 
from Biochemika-Fluka Analytical 01930-5G C10H12N5Na2O7P, Lot 
0001443266 
• Cytidine 5’-monophosphate disodium salt (CMP), 99%, F.W=367.16, 
from Sigma C1006-1G C9H12N3Na2O8P, Lot 109K1631 
• Guanosine 5’-monophosphate disodium salt (GMP), 99%, F.W=407.18, 
from Sigma G8377-5G C10H12N5Na2O8P x H2O, Lot BCBB5515 
• Thymidine 5’-monophosphate disodium salt (TMP), 99%, F.W=366.17 
from Sigma T7004-250MG C10H13N2Na2O8P, Lot 129K1338V 
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Nucleobases  
All were obtained from Sigma Aldrich  
• Adenine A8628-5G, C5H5N5, 99%: , F.W=135.13, Lot 108K0136 
• Cytosine C3506-5G, C4H5N3O, 99%:, F.W= 111.1, Lot 059K1010 
• Guanine G11950-25G, C5H5N5O, 98%, F.W= 151.13, Lot 03420LH 
• Thymine T0895-5G, C5H6N202, 99%, F.W=126.11, Lot 0001435947 
 
PBS 
PBS 1X Phosphate Buffered Saline solution without calcium & magnesium, pH: 
7.36, obtained from Cellgro Mediatech Inc. CAT No. 21-040-CV 
From scratch take the following to make 500 mL solution:   
10.9g Na2HPO4 
3.2g NaH2PO4 
90g NaCl 
500mL distilled H2O 
To adjust the pH add NaOH until final pH = 7.36 
 
Nanoparticles  
• α-Tocopherol, F.W=472.74, density=0.953 g/ml, Lot No. 1320538 was 
obtained from Fluka 
• L-A Phosphaditylcholine, obtained from Sigma Aldrich, F.W=776 g/mol, 
CAS No. 8002-43-5, Lot No. 119K5200, (See attachment 1 for MSDS) 
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• Palmitic Acid (Hexadecanoic Acid), obtained from Sigma appox 99%,  No 
P-0500 chemical formula is CH3(CH2)14COOH Anhyd mol wt 256.4  Lot 
42F-0615, (See attachment 1 for MSDS 
• Adherent cell Lysis solution was obtained from Origene, hypotonic lysis 
buffer lot No. 1010 
• N-Lauroylsarcosine sodium salt for Molecular Biology (Warning use 
Mask) from Sigma life sciences Pcode 1000678233, CAS-137-16-6, 
C15H28NNaO3, MW=293.38g Assay Spec >94% (used 2g in 10mL H2O) 
• BCATM Protein Assay Kit (bicinchoninic acid) obtained from Thermo 
Scientific product # 23225 Lot KL136078.  BCATM Protein Assay  is 
shown in Figure 8 
Contains:  
Product #23228 BCA Protein Assay Reagent A 
Product # 1859078 BCA Protein Assay Reagent B  
Prepared the working reagent by mixing 50 parts of BCA Reagent A with 
1 part of BCA Reagent B.  
• Hs27 Foreskin Human (Homo sapiens) from ATCC product code CRL-
1634 lot number 4012887 1mL volume ampoule containing 8.4 x 105 
cells. Tissue: Normal; foreskin. Age: Newborn. Gender: male. 
Morphology: fibroblast. Date frozen: 02/25/05. Expected Viability: 95% 
to 100%. 
17 
 
 
• Thermo Scientific Hyclone Classical Liquid Media Dulbeccos Modified 
Eagles Medium (DMEM) / High Glucose; without L-Glutamine and 
Sodium Pyruvate. Media; Cell culture; Liquid; Phenol Red. Catalog 
number SH30081.FS 
• Standard Fetal Bovine Serum Collected and processed in USA by 
HyClone. Triple 0.1 um Sterile Filtered Cat # SH30088.03 
• Amphotericin B Solution obtained from Sigma A2942  100mL  250 
μg/mL, Lot 0109M00052 
• Gentamycin solution from Sigma 10mg/mL in deionized water, liquid, 
sterile-filtered, BioReagent, suitable for cell culture. Prod # G1272 
• Trypsin 10x solution from Sigma T4549 Sterile filtered 
• PLGA – Poly(DL-Lactide-Co-glycolide)(50:50), inherit viscosity 0.15 – 
0.25  Aldrich 531154-16  mk BB7347 
• PEG – Polyethylene glycol from Sigma-Aldrich P3015-500g Batch # 
029K0174, CAS 25322-68-3 
• PVA – Polyvinyl Alcohol 98% hydrolyzed, from Aldrich  348406-25G 
Lot 04904DJ  CAS# 9002-89-5   
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Figure 8.  BCA Reagent 
•  
• http://www.piercenet.com/ 
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INSTRUMENTATION. 
All UV-Vis absorption intensity measurements were measured on Ocean Optics 
USB4000-UV-VIS (USB4F07697) and USB-ISS-UV/VIS (UUSC1562). 
Software to plot excitation and emission spectra was Logger Pro 3.8.2 Ver. Dtd. 
Feb 11, 2010 ISBN- 1-929075-24-3.  
Figure 9.  Ocean Optics UV-Vis  Spectrophotometer 
 
 
All luminescence intensity measurements were made on a Ocean Optics USB 
2000+, CuV, PX-2 spectrophotometer equipped with Spectra Suite Spectroscopy 
Software 2008 for o/s Win XP ver. 5.1 running X86.  The USB2000+ Miniature 
Fiber Optic Spectrometer is a powerful 2-MHz analog-to-digital (A/D) converter, 
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programmable electronics, a 2048-element CCD-array detector, and a high-speed 
USB 2.0 port. 
The PX-2 Pulsed Xenon Light Source was a high flash rate, short-arc xenon lamp 
for applications involving absorbance, reflection, fluorescence and 
phosphorescence measurements. Fluoremeter, integration time 2 sec, Scans to 
average 10, Boxcar width 10.   
Both sets of measurements used 1.0 cm quartz cuvettes.   
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Figure 10.  Ocean Optics USB2000 spectrophotometer 
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To obtain data of emission of the nanoparticles in the cells, the BioTek El x800 
with Gen 5 1.09 software to read @ 570 & 630, two times 24 well plate was used. 
 
Figure 11.  Bio Tek Fluorometer 
 
http://www.biotek.com/ 
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Finally to obtain the picture of the fluorescence nanoparticles inside the cells, the 
Olympus BX51 quality research microscope was used.  This instrument is capable 
of bright-field, dark-field, fluorescence, phase contrast and differential 
interference contrast (Normarski DIC) viewing of samples.  The DP 70 Digital 
Camera was used in conjunction with Olympus DP manager and DP Controller 
Software. 
 
Figure 12.  Olympus BX51 Microscope 
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2.B.  Methods 
To find out which nuclei base and nucleotide absorbs and/or emits the best for 
effective energy transfer; intensity of absorption was measured.  Then, emissions 
were measured after titration of lanthanides with each one of the nucleobases and 
nucleotides, respectively.  The absorption was performed using the Ocean Optics 
USB 4000-UV-VIS. Solutions were prepared in the dark, due to materials 
photosensitivity. Logger Pro 3.8.2 software was used to collect the data. Once in 
Logger Pro, experiment was picked, calibration was performed with a blank and 
once calibrated; data was collected, and exported as text to graph later.  In the 
same way emission was performed using Ocean Optics USB 2000+, 
spectrophotometer equipped with Spectra Suite Spectroscopy Software 2008  
 
Originally, the Stock solutions were prepared in PBS shown in Table 1. 
Performed the UV/Vis measurements, but realized when executing the procedure 
on the spectrophotometer, the phosphate in the PBS would interfere with the 
luminescence.  Stock solutions were redone in de-ionized water for the 
nucleotides at 5mM and nucleobases at 10mM, Table 2 shows the real 
concentrations obtained.  Afterwards, diluted the Bases to 100µM, 200µM, 
500µM and 1000µM, in addition, the nucleotides stock solutions were diluted to 
50 µM and 100µM, and then measured UV-Vis for all of them. In Table 3, the 
monophosphates nucleotides Stock solutions were prepared using de-ionized 
water. These nucleotides were used at a diluted concentration of 1mM when 
combined with the respective lanthanides. 
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The process called “titration of the lanthanide” was performed as follows:  
prepared stock solutions in de-ionized water for EuCl3 at 9.80mM, then diluted 
them to 100µM , 200µM, 500µM, 1,000 µM; likewise TbCl3 at 10.05 mM was 
diluted to 100µM, 200µM. The two lanthanides were diluted to a concentration of 
40 µM. 
 
Table 1.  Stock Solutions Bases and Triphosphates in PBS 
Nucleotide/Nucleobase Stock Solution 
(concentration mM) 
DATP 4.95 
DCTP 5.02 
DGTP 5.05 
DTTP 5.11 
Adenine 10.01 
Cytosine 11.58 
Guanine 10.59 
Thymine 9.68 
 
 
Placed 2mL of EuCl3 or then TbCl3 of the specified 40 µM concentration into a 
cuvette and titrated with each one of the nucleobases respectively, in increments 
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of 10 µL until the peak point of the curve had been reached, or stopped if the 
absorption/emission readings followed cycles without reaching a peak. 
 
Table 2.  Stock Solutions Bases and Triphosphates 
 
Nucleotide/Nucleobase 
 
Stock Solution 
(mM) 
 
Dilution 
mM 
 
Wavelenght 
ʎ 
DATP 8.69 1 375.81 
DCTP 5.39 1 375.81 
DGTP 3.21 1 486.82, 
529.32  & 
542.54 
DTTP 3.38 1 375.81 
Adenine 9.88 1 375.81 
Cytosine 10.03 1 375.81 
Guanine 10.00  
1 
486.82, 
529.32  & 
542.54 
Thymine 10.05 1 375.81 
 
 
Placed 2ml of EuCl3, then TbCl3 of the specified 40 µM concentration in a cuvette 
and titrated with each one nucleotides respectively, in increments of 10 µL until 
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the peak point of the curve had been reached, or stopped if the 
absorption/emission readings followed cycles without reaching a peak .The 
dilution concentrations of the triphosphates and bases were at 1 mM. 
Table 3.  Stock Solutions Monophosphates 
 
Nucleotide/Nucleobase 
 
Stock Solution  
(mM) 
 
Dilution 
mM 
 
Wavelenght 
ʎ 
AMP 9.97 1 375.81 
CMP 10.07 1 375.81 
GMP 10.00 1 486.82, 
529.32 & 
542.54 
TMP 10.01 1 375.81 
 
 
Stock solutions were prepared in de-ionized water for EuCl3 at 8.17mM and TbCl3 
at 8.04mM. The two lanthanides were diluted to a concentration of 40 µM when 
placed in a cuvette for measurements. 
 
Placed 2mL of EuCl3 of the specified 40 µM concentration into a cuvette and 
titrated with each one of the mono nucleotides in increments of 10 µL until the 
peak point of the curve had been reached, or stopped if the absorption/emission 
readings followed cycles without reaching a peak. 
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Preparation of Nanoparticles 
During our research two different kinds of Nanoparticles were prepared.  The first 
one was based on Governors State University thesis research by authors Bandaru 
and Fu. The researchers developed nanoparticles with PLGA-PEG polymer 
combination to increase the hydrophilicity of Rifampicin (RIF), a hydrophobic 
drug (26).  Their work, “Photo Physical Properties of Non- Encapsulated and 
Encapsulated Rifampicin:  A comparative study”, was the base for becoming 
familiar with the methods and measurement of fluorescence nanoparticles.  The 
hydrophobic nanoparticle was not a good fit for this research but helped to 
understand the delivery mechanism into the cells.  The second type of 
nanoparticles developed was based on nanoemulsion technology using two 
different types of surfactants.  Following is the description of the two methods 
pursued to develop hydrophobic and hydrophilic nanoparticles. 
 
Preparation of Nanoparticles with luminescence marker (Rivoflavin+Rifampicin) 
(26) 
• A calculated amount of Poly (DL-Lactide-Co-glycolide (PLGA) and 5% 
(w/v) polyethylene glycol (PEG) were dissolved in 2 mL of 
dichloromethane (DCM) in separate tubes. Then mixed for 30 minutes.  
• Prepared luminescence marker Rifampicin (RIF) 
• Prepared PVA solution. 
• The luminescence marker and the polymer solution PLGA and PEG were 
mixed and vortexed until emulsified. 
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• The emulsion was poured into PVA solution which led to the double 
emulsification of the particles. 
• Mixture from previous step was sonicated for 30 minutes then centrifuged 
for 15 minutes at 13000 rpm, washed with de-ionized water twice. 
Repeated centrifugation step 4 times, then resuspended in water and 
placed in the refrigerator for storage. 
 
Preparation of W/O/W Nanoparticles with luminescence Lanthanide marker  
The following drug delivery system allows the encapsulation of hydrophilic 
species into nanoemulsions.  The reverse-micellar system involved the 
solubilization of hydrophilic molecules (solutions of Eu3+ and Tb3+ with 
Guanosine 5’-monophosphate disodium salt hydrate (GMP), respectively, in oil 
(α-Tocopherol) to form a stable w/o emulsions (encapsulation of the marker).  
The reverse micelle–loaded oil was injected into an aqueous phospholipid or 
palmitic acid solution to form a w/o/w emulsion. 
 
The phase-transfer method for preparation of reverse micelles (27) was pursued. In 
this method the organic phase (oil) loaded with L-α Phosphaditylcholine or 
palmitic acid (surfactants) was titrated with the luminescence marker.  This phase 
was mixed with an aqueous phase containing its particular surfactant and phase 
separation occurred after equilibrium was reached.  The method follows: 
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1. Prepared the w/o emulsion:  oil plus particular surfactant was titrated with 
aqueous solution of Eu3+ and Tb3+ with GMP respectively.  Ensuring that 
the luminescent marker was added in the same ratio of energy transfer 
found in the emission experiments, as Eu(III) to GMP, ratio 1:11  with 
concentrations, Eu(III)at 40µM and GMP at 444 µM.  And TB(III) to 
GMP, ratio 1:10.7 with concentrations, TB(III)at 40µM and GMP at 428 
µM.  The process of preparation of the water in oil emulsion for the L-α 
Phosphaditylcholine surfactant began by measuring 5 mL (weight was 
4.94g) of α-tocopherol and mixed with 0.0019g of  L-α 
phosphaditylcholine (500 µM).  Likewise, measured 5 ml of α-tocopherol 
(weight was 4.72g) and mixed with 0.006 g of palmitic acid (500 µM).   
 
After the previous solution was made and in the process to be titrated with 
luminescence marker, it must be sonicated until no more water solution 
could be intake by the emulsion.  The L-α phosphaditylcholine emulsion 
titrated by the Eu(III) and GMP solution had a maximum intake 700 µL of 
the marker.  The Palmitic Acid emulsion had a maximum intake of 1200 
µL. In the same way, the L-α phosphaditylcholine emulsion titrated by the 
TB(III) and GMP solution had a maximum intake of 1200 µL and for the 
palmitic acid emulsion the maximum value of intake was 1500 µL. 
 
2. Sonicated the mixture for 1 hour, then centrifuged for 15 minutes at 13000 
rpm.  Decanted fluid.  
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3. Mixed w/o emulsion of step 1 with aqueous solution of surfactant L-α 
phosphaditylcholine or palmitic acid respectively.  The aqueous solution 
was prepared at a concentration of (250 µM) as follows:  
22 mL of de-ionized water were measured and mixed with 0.0043 g of L-α 
phosphaditylcholine.  The second solution consisted of 22 mL of de-
ionized water, mixed with 0.0014 g of Palmitic acid. 
4. Formation of double emulsion.  The addition of w/o to an aqueous 
surfactant solution formed a milky inverse emulsion. 
5. Sent samples to outside laboratory to find particle size through TEM 
images. 
 
Cell study 
Cell penetration study was performed to assess the diffusion and the releasing of 
the biosensor into the cells.  We obtained a good encapsulation of the 
hydrophobic luminescence biosensor (rivoflavin + rifampicin). The cell study was 
performed with this hydrophobic nanoparticle.  Cells obtained from ATCC were 
grown per the prescribed protocol (see below Cell Preparation Procedure); cell 
plates were washed with PBS two times. Then into a 24 well plate, 1mL of PBS 
was placed into 17 wells. Placement on the plate were as follows: by columns on 
the plate (4 wells) from left to right the following concentration of 0, 200, 400, 
and 800 uL of the nanoparticle and 1 well (5th column) had 1000 uL of the 
nanoparticle solution set as control. The plate was incubated for one hour.  A cell 
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lysis solution using N-lauroylsarcosine sodium salt was previously made.  
Discarded the solution from the 17 wells and added 500 µL of the lysis solution in 
each well, placed on an incubator shaker for overnight shake. After complete 
breakthrough of cells, took emission spectra at ʎ=530.39.  (Figure 30 and 31).  
The maximum emission was found at ʎ=530.39 with an intensity of 14,298.   
 
Cell Preparation Procedure 
1. Prepared modified DMEM Media food starting with one 500mL bottle of 
Hyclone DMEM/HIGH media. Added 50mL of Standard Fetal Bovine 
Serum to DMEM/HIGH media. Additional, added 2.5 mL of Gentamycin 
solution and 5.0 mL of Amphotericin B Solution to the DMEM/HIGH 
media. The Amphotericin B Solution and Standard Fetal Bovine Serum 
are stored in freezer. These two components must thaw out before added 
to DMEM/HIGH solution. Modified DMEM media placed in incubator to 
warm up to 37o C. 
2. Removed 1mL ampoule from cryogenic storage container. Allowed to 
thaw and placed into 750 mL flask with 50 mL modified DMEM media. 
Placed cell culture in incubator at 37o C and 5.0% CO2. 
3. Waited 24 hours, rinsed flasks with sterilized PBS solution twice and 
added 50 mL modified DMEM media to flasks. Returned to incubator. 
4. Waited 48 hours, checked progress of growth of cells. Changed modified 
DMEM media with fresh modified DMEM media. Repeated this cycle 
until flask was saturated with cells. 
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5. Re-plated cells starting with making 9mL de-ionized water to 1 mL 10x 
Trypsin solution.  Drained media from flask and washed with PBS 3 to 4 
times till all color was removed from flask. Added the 10mL Trypsin 
solution to the flask. Spread throughout flask and kept in incubator for two 
minutes. Took out of incubator and gave gently but stern slaps to the 
incubator to loosen cells from flask’s walls. Checked for any cell 
attachment using microscope. If still attached continue stern slapping of 
flasks. Once all cells all cells are floating. Then immediately add 50 mL of 
modified DMEM media, otherwise Trypsin will inactivate the cells. The 
modified DMEM media inactivates the Trypsin. Added additional 20 mL 
of modified DMEM media to flask. Proceeded to transfer 2 mL aliquots to 
40 circular Petri dishes. Added additional 1 mL of modified DMEM media 
for a total of 3 mL of solution in each Petri dish. Placed all Petri dishes in 
incubator.   
6. Returned 24 hours later and rinsed each Petri dish twice with PBS and 
placed 5 mL of modified DMEM media into Petri dishes and placed back 
in incubator to be checked at 48 hour intervals. 
7. At the 48 hour interval checked progress of cells in Petri dishes on the 
microscope. If dishes were not full then drained old media off and refilled 
with 5 mL of fresh modified DMEM media. Placed back into incubator. 
8. Once plates are full with cells, then plates can be used for further testing 
such as toxicity or preliminary uptake of nanoparticles. Precautions such 
as maintaining sterile conditions are extremely important. Do not touch 
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tips of containers. Proper pipetting techniques should be used. Never 
pipette from original bottles.   Transfer quantity needed to secondary 
bottle and pipette from this bottle. Lids of flask should not be too tight. 
Powder free latex gloves should be worn at all times when handling cell 
cultures and washed repeatedly with a 70/30 % ethanol to de-ionized 
water solution.  
 
As previously explained, hydrophilic nanoparticles were developed; these ones 
encapsulated the luminescent biosensor so cell study and toxicity were performed 
as follows: 
 
1. Had cells ready and then transferred them into the wells placing the same 
amount 250µL of cells in each well. Emptied out the media and washed 
the cell plates with PBS.  Put 1 mL of PBS in each one of the 17 Petri 
dishes.  
2. Incubated plate for one hour after placing the following amount of 
nanoparticles into the wells with cells: 
Control (no nanoparticles), 1ml, 2ml and 3 ml, and incubate for 1 hour. 
This procedure was followed for the de-ionized water in oil emulsions of 
palmitic acid and The L-α phosphaditylcholine as a concentration 
dependant study. 
At the same time placed the biosensor (Lanthanide + GMP) into the wells 
with the cells:    
35 
 
 
For Eu (III) at a concentration of 40 µM, 80 µM and 120 µM, GMP added 
at concentrations of 150 µM, 300 µM and 450 µM, 
For Tb (III) at a concentration of 40 µM, 80 µM and 120 µM, GMP added 
at concentrations of 150 µM, 300 µM and 450 µM.  
Plates were incubated for 1 hour. 
3. Took away the emulsions and do not wash with PBS.   
4. Put media back and incubated for 48 hours 
5. Performed toxicity test using BCA Reagent Assay Kit 
Toxicity test 
The BCA Protein Assay combines the well-known reduction of Cu2+ to Cu1+ by 
protein in an alkaline medium with the highly sensitive and selective colorimetric 
detection of the cuprous cation (Cu1+) by bicinchoninic acid. The first step is the 
chelation of copper with protein in an alkaline environment to form a light blue 
complex. In this reaction, known as the biuret reaction, peptides containing three 
or more amino acid residues form a colored chelate complex with cupric ions in 
an alkaline environment containing sodium potassium tartrate.   
 
In the second step of the color development reaction, bicinchoninic acid (BCA) 
reacts with the reduced (cuprous) cation that was formed in step one. The intense 
purple-colored reaction product results from the chelation of two molecules of 
BCA with one cuprous ion. The BCA/copper complex is water-soluble and 
exhibits a strong linear absorbance at 562 nm with increasing protein 
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concentrations. The BCA reagent is approximately 100 times more sensitive 
(lower limit of detection) than the pale blue color of the first reaction (28). 
 
The reaction that leads to BCA color formation is strongly influenced by four 
amino acid residues (cysteine or cystine, tyrosine, and tryptophan) in the amino 
acid sequence of the protein. However, unlike the Coomassie dye-binding 
methods, the universal peptide backbone also contributes to color formation, 
helping to minimize variability caused by protein compositional differences. (28) 
 
If the biosensor is toxic, then those cells killed have detached from the plate and 
are free floating.  These dead cells are then rinsed away when washing the plates 
with regular PBS. Therefore, the BCA test, as explained in the previous 
paragraphs, is measuring the protein content from only those cells left alive that 
undergo the lysis solution step.  This step, (lysis) has been determined to be 
highly critical in the accuracy of the toxicity test.  Any large portion of a well’s 
cells which are not lysis would give an undercount of the true value of absorbance 
compared if all cells were lysis.  Using the absorbance results obtained by the 
Micro plate reader, a ratio of absorbance of each concentration dependant series 
versus the three control wells’ would be determined.  This ratio when translated to 
a percentage would start the foundation of determining the LD50 for the given 
concentration which were tested and find if the biosensor is toxic.  The procedure 
used is as follows: 
1. Outside of the hood, washed plates twice with regular PBS 
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2. Put 1 mL of lysis solution 
3. Shook 15 minutes lightly at 100 rpm 
4. Prepared the BCA reagent as 50 parts of reagent A and 1 part of reagent B, 
a green solution was formed and the solution must be protected from the 
light. Added 3 mL of working reagent per sample. 
Reagent A:  Bicinchonic acid and tartrate in an alkaline carbonate buffer.  
Reagent B:  4% copper sulfate pentahydrate solution 
5. Transferred 1.1 mL of sample in a 24 well plate, replicated three times for 
each sample. 
6. Used the BioTek El x800 absorbance microplate reader with Gen 5 1.09 
software, and selected protocol1. Read Plates @ 570nm and 630 nm.  
 
Fluorescence Study  
1. Prepared 3 flasks of cells over a two week period. Fed cells per lab 
protocol using Standard Fetal Bovine Serum with Amphotericin B and 
Gentamycin. 
2. Re-plated grown cells using Trypsin to make cells detach from walls of 
flasks. Placed cells into five 100mm x 100mm square petri dishes this had 
two 75x25mm (1.0 – 1.2mm thick) pre-cleaned plain microscope slides. 
3. Cells grew for week. 
4. Prepared emulsions (L-α phosphaditylcholine + de-ionized water + α-
tocopherol) and (palmitic acid + de-ionized water + α-tocopherol) and 
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added Eu(III) + GMP and TB(III) + GMP to come up with four plates plus 
one control plate. 
5. Sonicated the emulsions for one hour, prepared square petri dishes, 
washed with PBS twice. Placed emulsions on slides in the square petri 
dishes and incubated for one and half hours. 
6. Using the Olympus BX-51 microscope (fFigure 12) filtered by the 
standard U-RSL 6 filter bar with attached DP 70 camera and using 
Olympus DP Manager and DP Controller software captured 
images (See Figure 33). 
7. Images captured were not well defined. Those images of (Palmitic 
Acid + de-ionized water + α-Tocopherol) and added Eu(III) + 
GMP and TB(III) + GMP   were the better of the images. 
8. Grew cells for week in flask, re-plated into three square petri dishes and 
let grow for another week. 
9. Sonicated only the emulsions of (palmitic acid + de-ionized water + α-
tocopherol) and added Eu(III) + GMP and TB(III) + GMP for two hours. 
Prepared square petri dishes, washed with PBS three times. Placed 
emulsions on slides in the square petri dishes and incubated this batch for 
three hours. 
10. Using the Olympus BX-51 microscope filtered by the standard U-
RSL 6 filter bar with attached DP 70 camera and using Olympus 
DP Manager and DP Controller software captured images (See 
Figure 34).  
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3. RESULTS AND DISCUSSION 
 
3.a.  Basic Spectroscopic Properties of Europium (Eu) and Terbium (Tb) 
The absorption spectrum of the lanthanides, bases and nucleotides give us 
valuable information concerning the initial step involved in any possible 
photochemical process.  A molecule may be excited in several different ways, 
depending on the frequency of radiation absorbed.  It is anticipated that the 
absorption causes displacement of outer electrons in the molecule because the 
frequency of radiation is in the visible and ultraviolet region of the spectrum (29).  
 
Europium (Eu) and Terbium (Tb) are part of the lanthanides, fifteen rare earth 
metal elements in the sixth row of the periodic table.  They are often referred to as 
4f-metals, because each new electron added as one proceeds from Lanthanum 
(La) to Lutetium (Lu) enters into the 4f-shell.  Furthermore, since the 4f-shell is 
located inside of the shell of the 5d6s-conduction state, the nature of the latter 
changes little as a function of atomic number.  The chemical properties of the 
lanthanide ions are very similar, since the 4f electrons are well shielded by the 5s 
and 5p electrons (30).  The most impressive feature about the spectra of rare earth 
(RE) ions in ionic crystals is the sharpness of the many lines in their absorption 
and emission spectra.  These lines can be as narrow as those commonly observed 
in the spectra of free atoms of free molecules.  The narrow optical lines suggest 
that the interaction or rare earths (RE) ions with the crystalline environment is 
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relatively weak (31).  Table 4 shows some basic spectroscopic information of Eu 
(III) and TB (III). 
 
The rare earths when solids are either divalent or trivalent.  By far the most 
common valence state of the RE ions in solids is the trivalent state with electronic 
configuration 4fN-15s25p6.  The 4f electrons are clearly not the outermost electrons.  
These electrons are shielded from external fields by two electronic shells with a 
larger radial extension (5s25p6), this explains the atomic nature of their solid state 
spectra.  Due to this shielding, the 4f electrons are only weakly perturbed by the 
charges of surrounding ligands.  This characteristic is why RE ions is such a 
useful probe in a solid. The crystal environment constitutes only a small 
perturbation on the atomic energy levels and many of their solid state, hence 
spectroscopic, properties can be understood from a consideration of the free ions 
(32).   
 
Eu (III) has been used in luminescence studies due to the unique 4f-to-4f 
absorption/emission band near 580 nm which cannot be split by a ligand field.  
Usually a tunable dye laser is necessary to study the Eu (III)’s 580 nm band 
because of the resolution and sensitivity needed for analysis of the band shape.  
Eu (III) is also the least stable lanthanide with respect to redox chemistry.  It’s 
reduction potential of about -3.5 V, depending on the coordination environment is 
within the range of weak biochemical reducing agents.  All other trivalent 
lanthanides have oxidation/reduction potentials unfavorable by 1 V or more.  
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Consequently, due to either instrumental or chemical reasons, it is not always 
possible to take advantage of some of the superior probe properties of Eu (III) (15). 
 
Table 4.  Basic Spectroscopic Properties of Eu & Tb in the trivalent state (32) 
Atomic 
Number Element 
Electron 
configuration 
RE(III) 
Ground Term 
RE(III) 
63 Europium (III) 4f65s25p6 7f0 
65 Terbium (III) 4f85s25p6 7f6 
 
TB (III) has 4f-to-5d absorption bands which provide an alternative to the 
demanding instrumental requirements of studying the 580nm band of Eu (III).  
Since the 5d orbitals are immediately exposed to the ligand field, the 4f-to-5d 
absorption bands move by thousands of wavelength numbers with changes in 
coordination, providing a convenient monitor of site multiplicity, and chemical 
exchange.  However, some of the TB (III) absorption bands are too far into the 
ultraviolet range to be studied with conventional fluorescent equipment and often 
overlap with ligand absorption bands. Energy transfer from intrinsic fluorophores, 
such as nucleic acids, generally gives rise to enhanced TB (III) (33) emission.  This 
is often not the case with Eu (III) if charge transfer occurs (15). 
Basically, all of the lanthanide absorption bands observed in the near-infrared to 
near-ultraviolet range of the spectrum are attributed to electric dipole transitions, 
although these transitions are parity forbidden since they occur between states 
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within the same configuration.  The magnetic properties of lanthanide ions vary 
appreciable along the series.  The ions La (III) and Lu (III) are diamagnetic. 
Among the paramagnetic ions, Pr (III), Eu (III) and Yb (III) have short electron 
spin relaxation time.  An extremely important application of lanthanides is the 
ability to get quantitative answers to conformational problems.  Enhancement of 
the luminescence of Eu (III) and TB (III) ions on biding to a ligand are capable of 
providing a detailed knowledge of the metal ions biding sites (30). 
 
3.b.  Absorption of Europium (Eu) and Terbium (Tb) 
Lanthanides are extremely weak absorbers with Europium and Terbium having 
shown weak absorption bands in the UV-Vis spectrum. No sharpness of lines are 
observed in their absorption spectra.  The absorption spectra of aquo-complexes 
showed values of extinction coefficients (ε) in the literature for TB(III) near 310 
M-1cm-1 at 220nm corresponding to the fully allowed 4f-to-5d band (15).  For 
Eu(III) the 7F1 state was only about 360 cm-1 above the 7F0 ground state and 
excitation from both levels was observed.  Unlike TB (III), the Eu (III) 5d levels 
lie well above 50,000 cm-1 and no 4f-to-5d absorption bands are observed above 
200 nm.  Like TB (III), Eu (III) had many 4f levels accessible within the visible 
and ultraviolet regions yielding a large number of absorption and emission bands 
(see Figure 4) (15). 
 
For a foundation for the research, the extinction coefficients for Eu (III) and Tb 
(III) were established as a measure of how strongly these lanthanides absorbed 
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light at a particular wavelength.  Dilutions from a stock solution generated four 
different solutions with the following concentrations:  100 µM, 200 µM, 500 µM 
and 1,000 µM of each one of the lanthanide ions, then the absorption of each 
solution were measured.  The excitation wavelength was λ =226.50 nm for Eu 
(III) and the average absorbance value for all the solutions were 0.21.  Likewise, 
the excitation wavelength for Tb (III) was λ =221.60 nm and the average 
absorbance value were 0.22.   
 
After finding the linear equation, that represented the relationship between 
concentration (X-Axis) and absorbance (Y-Axis) for the specific lanthanide ion, 
the value of the molar extinction coefficient (ε) was calculated (Figures 13 and 
14).  The calculation based on Beer’s law found that Eu (III) molar extinction 
coefficient was 457 M-1cm-1 and the one for Tb (III) was 477 M-1cm-1.  The 
experimental value of Tb (III) was close to the reference value of 310 M-1cm-1 at 
220 nm.  Details of the experimental conditions of terbium chloride in water can 
be found on the cited reference (15).  This wavelength presumed corresponds to the 
fully allowed transition 4f- to-5d.  An expected value to compare the molar 
extinction coefficient of Eu (III) was not available. 
 
The absorption spectra of the nucleic bases were analyzed.  The base adenine (A) 
dissolved in water at excitation wavelength λ max=260.5 nm had a molar 
extinction coefficient ε =7,772 M-1cm-1.  Literature research shows that adenine 
dissolved in water, pH 7, has a molar extinction coefficient of 13,400 M-1cm-1 at 
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261 nm (34).  Due to an expected low fluorescence yield, estimated to be 2.6x10-4 a 
fluorescence spectrum was not collected (35).   
 
The base cytosine (C) dissolved in water at excitation λ max=220.34 nm had a 
molar extinction coefficient ε =6,571 M-1cm-1.  Literature research shows that 
cytosine dissolved in water, pH 7, has a molar extinction coefficient of 6,100 M-
1cm-1 at 220 nm (34).  Due to an expected low fluorescence yield, estimated to be 
8.2x10-5 a fluorescence spectrum was not collected (35).   
 
Guanine (G) dissolved in water at excitation λ max=246 nm, had a molar 
extinction coefficient of ε =390 M-1cm-1.  Literature research shows that guanine 
dissolved in water has a molar extinction coefficient of 10,700 M-1cm-1 at 243 nm 
(34).  Due to an expected low fluorescence yield, estimated to be 3.0 x 10-4 a 
fluorescence spectrum was not collected (35). 
 
Finally, thymine (T) dissolved in water at λ max=263.2 nm, had a molar 
extinction coefficient of ε =5,075 M-1cm-1.  Literature research shows that 
thymine dissolved in water has a molar extinction coefficient of 7,900 M-1cm-1 at 
263.75 nm (34).  Due to an expected low fluorescence yield, estimated to be 
1.02x10-4 a fluorescence spectrum was not collected (35). 
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Figure 8.  Eu (III) absorption at wavelength max λ =226.5 nm 
 
 
Figure 9.  Tb (III) absorption at wavelength max λ = 221.6 nm 
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The same procedure was followed to measure the absorption of the nucleotides.  
dATP in aqueous solution had a wavelength maxima of λ =261.55 nm and a molar 
extinction coefficient of ε=13,189 M-1cm-1.  Likewise dCTP in aqueous solution 
had a λ max=220.32 nm and ε =7,896 M-1cm-1; dGTP had a λ max=253.28 nm 
and ε =8,821 M-1cm-1; finally dTTP had a λ max=266.84 nm and ε =6,607 M-1cm-
1.  There were not literature values available to compare the accuracy of the 
results.  However, the molar extinction coefficients were similar to the values 
found for the respective bases, which would be a good indication of the validity of 
the nucleotides absorption results. 
 
Based on the experimental data for wavelength maxima (λ max) and extinction 
coefficient (ε), it was clear that the values for adenine and guanine were different 
than the ones reported in the literature.  Cytosine and to a lesser degree thymine 
extinction coefficients were the only nucleotides comparable with the expected 
values.  The extinction coefficient (ε) is a characteristic of the solute and 
depending upon the wavelength of light, the solvent and temperature, any change 
in the experimental conditions can be the cause for inaccuracy.  Literature 
research states that membrane systems are probably the most difficult to study, 
due to their unavoidable turbidity and tendency to settle (15).  The differences in 
absorption values of the nucleic acids can be attributed to its physical 
characteristics.  Because, centrifugation and microfiltration were not performed 
on the nucleic bases or its nucleotides in order to avoid turbidity and precipitation.  
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The homogeneity of the sample might be compromised in the absorption and 
emission readings.  
 
3.c.  Emission of Europium (Eu) and Terbium (Tb) 
The purpose of the emission experiments was to determine the best concentration 
in which effective energy transfer from the donor, nucleic bases and nucleotides, 
to the acceptor, trivalent ion, would occur.  After many trials of adding nucleic 
bases (donor molecule) to a fluorescent trivalent ion solution (acceptor ion) at 
different concentrations, the best array of concentrations for efficient energy 
transfer was finally devised.  The initial concentration of the trivalent ions was set 
at 40 µM. Aliquots were added in increments of 10 µL, of nucleic acids at 10 mM 
stock solution, to each one of the trivalent ions.  Similarly, aliquots were added in 
increments of 10 µL, of nucleotides at 1 mM stock solution, to the respective 
aqueous trivalent ions solution.  We called this process, titration of the trivalent 
lanthanide ion by either nucleic bases or nucleotides.  Spectra emission was 
obtained but for analysis focus was on the visible spectrum. Also, notice the 
excitation readings at a single wavelength were not performed. 
 
A solution containing 40 µM Eu (III) or Tb (III) was weakly emissive upon 
excitation, due to the low extinction coefficient of the lanthanide ion.  Since 
nucleic acids exhibit large absorption cross sections in the 250-280 nm range (1), 
energy transfer (EnT) from the excited base to the emissive state 5D0 of bound Eu 
(III) or 5D4 of Tb (III) is possible.  Although Tb (III) excitation can involve the 5d 
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levels, there is rapid internal conversion of all excited states to the 4f5D4 level, 
from which virtually all the emission occurred (15).  The enhanced Eu (III) or Tb 
(III) luminescence in the presence of each nucleic base was established.  The 
relative emission intensity of 40 µM Eu (III) with increasing concentration of 
each nucleic base is shown in Figures 15 and 16.  Similarly, the relative emission 
intensity of 40 µM Tb (III) with increasing concentration of each nucleic acid is 
shown in Figures 17 and 18.   
 
The relative emission intensity of 40 µM Eu (III) spectra at λ=375.81 nm, 486.82 
nm and 542.54 nm with increasing concentration of each nucleic bases displayed 
decreasing behavior for overall luminescence for A (adenine), C (cytosine) and T 
(thymine).  As the aliquots at the following concentration; A (adenine 9.88 mM), 
C (cytosine 10 mM), and T (thymine 10.05 mM) were increased, there was no 
enhancement of Eu (III).  Significant enhancement of the Eu (III) emission 
intensity at λ=375.81 nm and 542.54 nm was observed upon addition of G 
(guanine) which was quite the opposite of A, C, and T. (Figure 15 and 16).   
 
The relative emission intensity of 40 µM Tb (III) spectra at λ =375.81 nm and 
542.54 nm with increasing concentration of each nucleobase showed decreasing 
behavior in the overall luminescence for adenine, cytosine and thymine bases.  As 
the aliquots at the following concentration; A (adenine 9.88 mM), C (cytosine 10 
mM), and T (thymine 10.05 mM) were increased, there was no significant 
enhancement of Tb (III).  In contrast, important enhancement of the Tb (III) 
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emission intensity at λ =375.81 and 542.54 nm was observed upon addition of G 
(Figure 17 and 18).   
 
From the analysis of the emission results with nucleic bases, it was deduce that 
only one of the bases showed effective enhancement.  Guanine displayed 
emission for both Eu (III) and Tb (III).  It is known that strong chelation of Tb(III) 
in water is better accomplished by ligands that possess two or more adjacent 
electron density rich regions, especially when at least one of them is an oxygen 
atom (36). Inspection of the structures of the nucleic acids (Figure 1) revealed that 
this is only possible in C (through O2 and N3) and G (through O6 and N7).  The 
difference in enhancement between C and G may be due to differences in 
quantum yield or triplet state formation or differences in binding stability and 
kinetics (1). 
 
The relative emission intensity of 40 µM Eu(III) and Tb(III), at λ=375.81 nm and 
542.54 nm was measured as the concentration of  2’ Deoxy 5’-triphosphate 
disodium salt of each nucleobase, dATP, dCTP, dGTP and dTTP, was increased 
(Figure 19 through 22).  It was expected that dGTP or dCTP would show 
luminescence enhancement.  Surprising results were obtained when none of the 
nucleotides showed emission.   
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Figure 10.  Emission of Eu (III) with nucleobases at λ=375 nm 
 
 
 
Figure 11.  Emission of Eu (III) with nucleobases at λ =542.54 nm 
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Figure 12.  Emission of Tb (III) with nucleobases λ =375 nm 
 
 
 
Figure 13.  Emission of Tb (III) with nucleobases at λ =542.54 nm 
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Apparently, there was no energy transfer due to phosphate interference and 
impractical binding with the three phosphates available for complexation (Figure 
2, dGTP).  Previous studies measured the emission intensity of 25 µM of Tb (III) 
as the concentration of that 5’ deoxymonophosphate disodium salt of each 
nucleobase, dAMP, dCMP, dGMP, and dTMP was increased.  As previously 
reported, only dGMP, showed enhancement of Tb (III) emission (1). Therefore, we 
performed fluorescence experiments using 5’-monophosphate disodium salt of 
each nucleobase, at concentration of 1 mM respectively (Figure 2, GMP). 
 
The relative emission intensity of Eu(III) and Tb(III) spectra at λ=486.82 nm and 
542.54 nm was measured as the concentration of the 5’-monophosphate disodium 
salt of each nucleobase (1mM), AMP, CMP, GMP and TMP, was increased 
(Figure 23 through 26).   
 
Only GMP showed a slight enhancement of the Eu (III) emission at 486 nm but 
no enhancement at 542 nm (Figure 23 and 24).  Addition of similar concentrations 
of AMP, CMP, and TMP to Eu (III) did not appear to enhance the luminescence 
of the lanthanide ion.  Relatively, for Tb (III), GMP showed considerable 
enhancement of the Tb (III) emission at both wavelengths 486 nm and 542 nm 
(Figure 25 and 26).  A negligible degree of enhancement for Tb (III) was formed 
by addition of AMP at 486 nm but not at 542 nm.  Addition of similar 
concentrations of CMP, and TMP to Tb (III) did not appear to enhance the 
luminescence of the lanthanide ion.  
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Figure 14.  Emission of Eu (III) with triphosphate nucleotides at λ=375 nm 
 
 
 
Figure 15.  Emission of Eu (III) with triphosphate nucleotides at λ =542.54 nm 
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Figure 16.  Emission of Tb (III) with triphosphate nucleotides at λ =375 nm 
 
 
 
Figure 17.  Emission of Tb (III) with triphosphate nucleotides at λ =542.54 nm 
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As reported previously by various authors, dGMP led to enhancement of the Tb 
(III) emission, whereas the other nucleotides did not (37) (1). Comparably, the 
emission experiments found the base, guanine (G), and its nucleotide, 5’-
monophosphate disodium salt (GMP), enhanced the luminescence of both 
trivalent ions.  Among the bases and nucleotides, GMP, was the ligand that 
enhanced the luminescence of both lanthanide ions to a greater extent.  However, 
GMP bound to Tb (III) appeared to be more emission efficient than bound Eu 
(III).  The difference in emission could be explained based on water interference, 
deactivation pathway, or/and energy transfer (EnT) efficiency parameters. 
 
First, it is believed that Eu (III) sensitive emission state is weaken by water 
molecules interference and its deactivation pathway is affected.  Upon ligand 
excitation in the presence of Tb (III) or Eu (III) two mechanisms for the 
enhancement of the lanthanide emission are possible in water.  Energy transfer 
from the excited ligand to Tb (III) or Eu (III) is expected to provide the largest 
enhancement, although a small increase in the emission intensity could arise from 
the replacement of water molecules from the first coordination sphere of the ion 
by other ligands, resulting in a decrease of the excited state deactivation through 
the O-H vibrational modes of coordinated water molecules.  Whereas the former 
is dependent on the excitation wavelength (where the ligand absorbs), the latter is 
not.  However the emissive state of Tb (III) is not as sensitive to water vibronic 
deactivation compare to that of Eu (III) (1).  Since the coordination sphere of the 
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lanthanide ion is saturated by the ligand, the ability of water to quench the 
luminescence is small (25).   
 
Second, the difference in emission between, bound Eu (III) and Tb (III) can be 
justified by EnT parameters.  Energy transfer (EnT) takes place from the excited 
base of a given base (donor) to the emissive state 5D0 of bound Eu (III) or 5D4 of 
Tb (III).  The efficiency of the EnT process depends on the binding of the 
lanthanide to the base, rate of energy transfer, and quantum yield of formation of 
the ligand donor excited state.  The study of these efficiency parameters is out of 
the scope of our research but nevertheless helps in the explanation of the 
lanthanides fluorescence behavior. It is believed that the emission differences 
between the two lanthanide complexes could be explained by either the quantum 
yield of formation of the triplet state of the donor or to differences in binding of 
Eu (III) to each nucleotide.   
 
It has been reported that cytosine (C) and dGMP had the best EnT performance 
when bounded to Tb (III).  That study established excited-state kinetics of the 
nucleotides is known to be very similar to those of the corresponding bases (1).  
So, being cytosine, a great ligand, we expected that dCMP followed the trend.  
However, CMP bounded to the lanthanide ions was not emissive at all.  The 
observed differences in energy transfer to the lanthanide ion between CMP and 
GMP could be explained by variations in binding of the trivalent ion in the 
presence and absence of the anionic phosphate group.  It appeared that in CMP 
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the Tb (III) and Eu (III) bounded to the phosphate group could be too far away 
from the base for effective energy transfer.  The difference between GMP and 
CMP could be due to the ability of the phosphate to fold over and interact with the 
lanthanide ions trough O6 and N7 in GMP, whereas an analogous fold over in 
CMP did not take place.  In the cases of G and GMP, the phosphate group 
appeared to aid in binding of the donor and acceptor.  Research had shown that 
GMP is a better energy transfer donor in the order GMP> GDP > GTP (16) (17).  
This fact is supported by the initial experiments where dGTP did not show any 
enhancement for the trivalent ions.  When we replaced the triphosphate by 
monophosphate, the process of energy transfer happened.  The difference in 
binding between dGTP and GMP can be explained in terms of phosphate 
interference and molecular geometry for the binding with the trivalent ions.   
 
The emission experiments discovered the best ratio for effective energy transfer 
(Figure 27).  The ratios were: Eu (III) to GMP 1:11 and Tb (III) to GMP 1:10.7.  
The concentrations at which effective EnT happened were:  Eu (III) plus GMP at 
444 µM; and Tb (III) plus GMP at 428 µM.   
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Figure 18.  Emission of Eu (III) with monophosphate nucleotides λ =542.54 nm 
 
 
 
Figure 19.  Emission of Eu (III) with monophosphate nucleotides λ =486.82 nm 
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Figure 20.  Emission of Tb (III) with monophosphate nucleotides λ =542.54 nm 
 
 
 
Figure 21.  Emission of Tb (III) with monophosphate nucleotides λ =486.82 nm 
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Figure 22.  Energy transfer of complex Eu (III) + GMP and Tb (III) +GMP 
 
 
 
3.d.  Design of Nanoparticles 
After finding the best ratio for efficient EnT, the fluorescence biosensor has to be 
transported into the cells. As a means of delivery system, nanoparticles can 
encapsulated and protect the biosensor.  One way to create the nanoparticles is 
through the formation of nanoemulsions.  Nanoemulsions are a class of emulsions 
with a droplet size between 20 and 500 nm (38).  Their droplets are stabilized by 
surfactants.  They are not formed spontaneously; their properties depend not only 
on thermodynamic conditions but on preparation methods and the order of 
addition of components. Nanoemulsions can be used as micro reactors of 
controlled size for the preparation of mono-disperse particles (38). 
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We followed two different design schemes. The first one was based on Governors 
State University thesis research about Rifampicin, an antibiotic that has been 
widely used as an anti-tubercular drug.  It has been shown that the nanoparticles 
with PLGA-PEG polymer combination increase the hydrophilicity of Rifampicin 
(RIF), a hydrophobic drug.  Using the highly fluorescence property of Rifampicin 
as a tool, it was proven that the drug was encapsulated successfully (26).  The 
thesis work, “Photo Physical Properties of Non- Encapsulated and Encapsulated 
Rifampicin:  A comparative study”, was the base for becoming familiar with the 
methods and measurement of fluorescence nanoparticles.  A TEM picture of the 
encapsulated RIF inside the NP is shown in figure 28.   
 
The second scheme was the design of double or inverse emulsions (w/o/w) to 
create nanoparticles (Figure 29).  Several surfactants were tested to encapsulate 
the hydrophilic biosensor. After extensive literature research and experimentation, 
two surfactants were chosen for the nanoparticles production.  One surfactant was 
palmitic acid and the other L-α phosphaditylcholine (known as lecithin).   
 
We selected these two surfactants based mainly on their compatibility with 
biological systems, their stability during storage, and efficacy after administration 
into the body.  First, L-α phosphaditylcholine, is a major structural component of 
cellular membranes in eukaryotic cells.  Secondly, phosphatidylcholine serves as 
a reservoir for several lipid messengers.  Finally phosphatidylcholine is used for 
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preparation of vesicle suspensions commonly called liposomes or as monolayers 
(39). 
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Figure 23.  Hydrophobic nanoparticles 
 
Figure 24.  Hydrophilic nanoparticles 
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Similarly, palmitic acid or hexadecanoic acid is one of the most common 
saturated fatty acids found in animals and plants and has low toxicity.  We sent 
our nanoparticles with the encapsulated biosensor to University of Illinois at 
Chicago for proper assessment of particle size due to the lack of TEM equipment 
(transmission electronic microscope).  Our findings can be visualized in Figure 
29, which shows the encapsulation of the biosensor into 75 nm particles made of 
palmitic acid.   
 
We tested the efficiency of the nanoparticles delivery into the cells.  The 
hydrophobic nanoparticles, made of a combination of PLGA-PEG polymer, were 
added into cells we had previously grown.   
 
The initial checks for emission were hampered due to the difficulty in the cells 
lysing.  After sonication and shaking for several days, two separate samples 
(Figure 30 and 31) that displayed emission were obtained.  Figure 30 exhibited 
the fact the NP had entered into the cells.  Figure 31 showed such a high emission 
that the NP’s themselves had fragmented besides the cells bursting.  The highly 
fluorescence property of Rifampicin as a tool proved that the drug is encapsulated 
successfully. 
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Figure 25.  Emission of hydrophobic nanoparticles. 
 
 
 
 
Figure 26.  Bursting of hydrophobic nanoparticles. 
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Similarly, the emission of the palmitic acid nanoparticles that encapsulated the 
hydrophilic biosensor was tested.  Unfortunately, the particle size for the L-α 
phosphaditylcholine nanoparticle was not appropriate for analysis. The emission 
result for the palmitic acid nanoparticles is shown in Figure 32.  It was clear that 
GMP enhanced the emission of the lanthanide Tb (III) in a higher degree than Eu 
(III).  The addition of a surfactant like palmitic acid to the solution aided the 
luminescence enhancement of the ligand-lanthanide complex.  Adding this 
surfactant created inverse micelles that helped in the formation of nonpolar 
regions in an aqueous solution.  When the complex was added in vitro, there was 
a sustained release.  The initial burst released the luminescence biosensor 
effectively, confirming that the nanoparticles burst and the protein was released.  
In contrast, since GMP led to a lesser degree of enhancement of Eu (III), the 
complex added in vitro did not show release of the biosensor.  This behavior 
suggested that most of the proteins remained in the nanoparticles.   
 
The performance of Eu (III) complex can be explained by the EnT mechanism 
and impurities that may affect the biosensor emission.  It is believed that GMP is 
usually remote relative to bounding the lanthanide Eu (III), so the effect in EnT is 
weaker than in Tb (III) and the emission fluorescence effect is reduced.   Also, the 
formation of impurities such as Eu (II) ion may diminish the emission.  The in 
vitro results were in agreement with the findings of the emission studies.  Tb (III) 
was a better quencher than Eu (III) when bound to dGMP, and its emission in 
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vitro studies reinforced this fact.  Encapsulation of the biosensor offered 
successful delivery of it inside the cells. 
 
Figure 27.  Fluorescence of encapsulated Eu (III) and Tb (III) 
 
 
Finally to confirm the fluorescence release of the biosensor into the cells, pictures 
of the emission of the nanoparticles were taken.  This was done using the 
fluorescence capturing capability of the Olympus BX-51 microscope in 
conjunction with the DP 70 camera , the picture was taken  under oil  (oil is place 
on the slide), and the size magnification means 100X multiplied by 10X equaled 
1000X (times) magnification.  Figure 33 shows the fluorescent L-α 
phosphaditylcholine nanoparticles, in which the nanoparticles’ size, were not 
reach.  Figure 34 shows the emission of 75 nm palmitic acid nanoparticles. 
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Figure 28.  Fluorescence of L-α phosphaditylcholine NPs into the cells 
 
 
Figure 29.  Fluorescence of palmitic acid NPs into the cells 
 
 
 
 
3.e. Toxicity Study 
 The in vitro toxicity of the nanoparticles, with both luminescence 
biosensors, was assessed by BCA assay.  As shown in Figure 35, the results were 
satisfactory.  The nanoparticles were non toxic and all their values were above the 
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LD50 (Lethal Dose 50%).  An LD50 is a standard measurement of acute toxicity 
that is shown as percentage of cells growth as concentration dependant in 
milligrams (mg) of biosensor per kilogram (kg) of nanoemulsion.   
The acute toxicity values of LD50 represented the individual dose required to kill 
50 percent of a population of cells. Because LD50 values are standard 
measurements, it might be possible to compare relative toxicities among 
biosensors.  The lower the LD50 dose, the more toxic the biosensor will be.  
.Using the absorbance results obtained by the micro plate reader, a ratio of each 
sample concentration versus the three control wells’ absorbance would be 
determined. This ratio was translated to a percentage.  The biosensor of Eu (III) 
53% value represents that almost half of the cell population still alive, at the same 
concentration, the biosensor of Tb (III) showed 88% of the cell population 
survived.  Results supported that both luminescence nanoparticles biosensors 
were non toxic.  Nanoparticles of Eu (III) seemed to be more toxic than the ones 
of Tb (III). 
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Figure 30.  Biosensor Acute Toxicity 
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4. CONCLUSIONS 
 
The lanthanides trivalent ions, Eu (III) and Tb (III), prove their importance as 
luminescent biosensors. The luminescence enhancement of Eu (III) and Tb (III) 
emissions was utilized to probe the interaction between nucleic bases and the 
trivalent ions. It was found that guanine enhances both of the trivalent ions 
emissions with Tb (III) being a better acceptor.   
 
The unanticipated results of lacking enhancement for the base cytosine bounded 
to Tb (III) and Eu (III) is difficult to explain.  First, minor fluorescent impurities 
can make significant contributions and may contribute to wrong results.  Second, 
unpolarized excitation light, such as “natural light” will lead to a photo selection 
of fluorophores. Finally, as discussed in the poster presentation in Hawaii, 
problem with luminescence in an aqueous solution is that another pathway is 
available for deactivation of the excited state of the lanthanide, in the form of 
vibrational energy transfer to water molecules in particular.  This quenching of 
luminescence was minimized by using ligands which tended to encapsulate the 
lanthanide ion.  Furthermore, supported by literature findings, energy transfer 
from intrinsic fluorophores, such as nucleic acids, generally give rise to enhanced 
Tb (III) emission.  This is often not the case with Eu (III) if charge transfer occurs 
(15). 
The Luminescence enhancement of Eu (III) and Tb (III) was used to probe the 
interaction between the nuclei bases and the deoxytriphosphate bases. It was 
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found the base Guanine enhanced the luminescence of both lanthanides but dGTP 
did not, indicating that the lanthanide bound to the phosphate group is too far 
away from the base for effective energy transfer. Eu (III) is generally found to be 
a more effective quencher than Tb (III). 
The advantage offered by fluorescence measurements (over the absorption) are 
the greater sensitivities and lower concentration limits achievable with the 
excitation spectra. 
 
The w/o/w double emulsion technique successfully created nanoparticles which 
encapsulated the water soluble biosensor.  The particle size achieved was 75nm, 
which falls into the nanoemulsions range.  Accomplished was the release of the 
biosensor in vitro and the stability of the emulsion was proved.  The nanoparticles 
could be easily concentrated in the lymphatic system by intramuscular injection 
with no toxic effects.  
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5. FUTURE GOALS 
 
A researcher could gain further information about the topography of the 
biosensor, by variation of conditions, such as pH, ionic strength, viscosity and 
temperature.  Also, a good measurement of efficient EnT would be the 
determination of fluorescent lifetime.  In addition, the designing of an emission 
system to maximize the energy transfer by single strand DNA, (SSDNA), 
encapsulation instead of inverse micelles nanoparticles. 
 
In the area of nanoparticles characterization, it would be valuable to analyze 
particle size of the nanoparticles by dynamic light scattering (DSL) technique, to 
get a more accurate idea of particle size distribution. 
 
A researcher could assess the interaction of the nanoparticle with lipoproteins in 
blood that may lead to premature release of the marker. By increasing the 
permanence of the phospholipids nanoparticles could increase blood circulation 
times and with the enhanced stability could control in vivo release of the 
biosensor. 
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